Fi­bro­sis start­up touts mid-stage NASH tri­al as it moves sole can­di­date for­ward

A Pe­ter Thiel-backed biotech is re­port­ing a pos­i­tive tri­al in NASH — but it’s not plan­ning on work­ing there for the time be­ing.

Chemomab Ther­a­peu­tics, orig­i­nal­ly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER